Remove 2019 Remove Governance Remove Public Health
article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. But perhaps other forms of public health benefit would outweigh these harms?

article thumbnail

France to enable rapid market access for digital therapeutics

Healthcare It News

French president Emmanuel Macron has announced plans to follow in Germany’s footsteps by making digital therapeutics available on prescription through the statutory health system. I’m very direct with you – we will just replicate what works in Germany.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

InterSystems cloud integration service comes to NZ and more briefs

Healthcare It News

The French IT company was recently awarded a contract worth A$242 M ($159 million) to continue supporting the digitalisation of the WA public health system for the next five years. It has been working with HSS on the digital transformation of WA Health since 2019.

article thumbnail

ONC says stakeholders can 'pick up and run' with new regs

Healthcare It News

The second version of ONC's Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing and Public Health Interoperability rule, or HTI-2, is designed to support the data exchange needs of patients, providers, payers and public health agencies.

article thumbnail

Tasmania transforming outpatient services with online booking, eReferral system

Healthcare It News

The Tasmanian government has recently released a four-year strategy to transform outpatient services across its public health system. The state government has also made a A$150 million ($100 million) investment over four years to upgrade its digital health infrastructure.

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. public investment in the development of mRNA COVID-19 vaccines between 1985 to 2019.

article thumbnail

HIMSS22 Europe: ‘We need to develop eco-friendly digital health’

Healthcare It News

As well as climate change, healthcare is facing the threat of antimicrobial resistance (AMR), which has been dubbed ‘the silent pandemic’ Nancy Jennings, health advisor and AMR lead for the UK Mission to the EU, said that the issues of AMR and climate change were linked and needed to be treated with a similar approach.

Hospitals 345